Form D · Biotechnology
PSYLIN NEUROSCIENCES INC
San Diego, CA · CIK 0001388636
Offering snapshot reported Aug 25, 2009 · SEC filing
- Reported sold
- $5M Offering amount: $10M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 29, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 25, 2009 | Initial | $5,000,000 | No comparison | 2 | SEC filing |
| Mar 1, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 29, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-99578
Source: Form D, filed Aug 25, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark J. Gergen | Director, Executive |
| Michael Hanley | Director |
| Henry G. Jarecki | Director |
| Emer Leahy | Director, Executive |
| William E. Rote | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9360 Towne Center Dr
San Diego, CA, 92121
San Diego, CA, 92121